Casey Pierce, MD
Orthopaedic Surgery · Birmingham, ALNPI 1982958245
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Seapearl East, Inc at 43.6% of the total. Reporting peaked in 2019 at $2,118 and has fallen 56.2% since, to $928 in 2025.
Across 106 payments — averaging $68.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$3K
- Johnson & Johnson$917
- Medical Device Business Services, Inc.$898
- Stryker$641
- Pacira Therapeutics, Inc.$312
- Arthrex$268
- plus $1K from 12 others
Across 5 payments — averaging $1567.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$8K
What the payments were for
- Travel & lodging$1,24917%
- Food & beverage$3,49548%
- Education$2,51135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 13 | $3,160 |
| Johnson & Johnson(2 entities) | 28 | $917 |
| Medical Device Business Services, Inc. | 10 | $898 |
| Stryker | 10 | $641 |
| Pacira Therapeutics, Inc. | 12 | $312 |
| Arthrex | 2 | $268 |
| Zimmer Biomet | 5 | $258 |
| Medtronic | 1 | $167 |
| Ferring Pharmaceuticals Inc. | 8 | $141 |
| Smith+Nephew | 3 | $130 |
| Pacira Pharmaceuticals Incorporated | 4 | $115 |
| Bioventus LLC | 2 | $63 |
| Davol Inc. | 1 | $60 |
| Amgen | 3 | $43 |
| Globus Medical | 1 | $31 |
| Vericel Corporation | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,255 in reported general payments places this provider in the 70th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $586 |
| Methylprednisolone | 29 | $165 |
| Meloxicam | 23 | $99 |
| Mupirocin | 13 | $83 |
| Tramadol Hcl | 21 | $61 |
| Oxycodone Hcl | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Birmingham
- Jeffrey DugasBirmingham$11.5M
- Benton EmblomBirmingham$3M
- Herrick SiegelBirmingham$1.2M
- Kenneth MooreBirmingham$342K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$217K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
- Daniel KimBirmingham$147K
- Eugene BrabstonBirmingham$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.